Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Myths and Misconceptions About Uterine Fibroids
  • USA - English


News provided by

MCPR, LLC

Jul 25, 2017, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Kecia Gaither
Dr. Kecia Gaither

New York, NY (PRWEB) July 25, 2017 -- The vast majority of American women are expected to develop uterine fibroids at some point in their lives. But despite its prevalence, this much-misunderstood condition is surrounded by myths and misconceptions, according to perinatal consultant and women’s health expert Kecia Gaither, MD.

Women trying to understand their risk of developing fibroids – and their options if they’re diagnosed – are often thwarted by misinformation circulating about this potentially confusing condition.

Post this

About 70% of white women and 80% of African-American women have fibroids – non-cancerous tumors growing within the wall of the uterus – by the time they reach age 50, according to the National Institutes of Health. This important public health concern leads to more than $2 billion in direct health care costs each year.

“Women trying to understand their risk of developing fibroids – and their options if they’re diagnosed – are often thwarted by misinformation circulating about this potentially confusing condition,” explains Dr. Gaither, a double board-certified physician in OB/GYN and Maternal Fetal Medicine who holds a master’s degree in public health. “It’s crucial to set the record straight about fibroid facts versus fiction.”

Fibroid facts vs. fiction
What are some of the most common myths about fibroids? Dr. Gaither details 5 common myths and offers the truths for each.

Myth: All women with fibroids will experience symptoms.
Fact: Between 50% and 80% of women with fibroids won’t have any symptoms, such as pain or heavy menstrual bleeding. “Many women with fibroids don’t even know they have the condition,” she says.

Myth: Fibroid tumors will become cancerous.
Fact: This almost never happens. Uterine fibroids, which are known medically as leiomyomas, are nearly always benign, with far less than 1% turning malignant. “Having fibroids also doesn’t increase a woman’s chance of developing reproductive system cancers,” Dr. Gaither notes.

Myth: Untreated fibroids will continue to grow.
Fact: Since fibroid growth is fueled by estrogen, they grow and shrink in alignment with a woman’s hormone levels throughout her life. In pregnancy, existing fibroids may grow and new ones may form as estrogen levels heighten. On the flip side, fibroids usually shrink after menopause as the ovaries cease making estrogen.

Myth: Ultrasound is the best imaging tool to diagnose fibroids.
Fact: Pelvic ultrasound is indeed a common method of revealing fibroid growth, but doesn’t work as well as a pelvic MRI scan, Dr. Gaither says. “Ultrasound often underestimates the number, size and location of a woman’s fibroids,” she adds.

Myth: Women with fibroids must seek medical treatment.
Fact: If fibroids don’t cause any symptoms, which can also include pelvic pressure and frequent urination, then treatment isn’t necessary, Dr. Gaither says. “The one exception would be if the fibroids, while asymptomatic, are causing repeat miscarriages or infertility,” she says.

How are uterine fibroids treated?
When treatment for fibroids is deemed necessary – typically because symptoms have been pervasive and problematic – a variety of approaches may be taken. These include:
• Medications that shrink fibroids, including so-called gonadotropin-releasing hormones that typically bring on symptoms of menopause. “Drugs that block the hormone progesterone can also slow or stop fibroid growth,” Dr. Gaither notes. “Medications may also reduce the heavy bleeding and painful periods fibroids can cause.”
• Progestin-releasing IUDs, or intrauterine devices. “Women whose fibroids don’t distort the inside of their uterus can have this type of IUD placed, which reduces painful, heavy bleeding from the fibroids,” says Dr. Gaither.
• Hysteroscopy, which destroys fibroids protruding into the uterine cavity with electricity or a laser beam.
• Endometrial ablation, which destroys the uterine lining and can help women with small fibroids.
• Uterine artery embolization (UAE), which injects tiny particles into blood vessels to the uterus, cutting off blood flow to fibroids.
• Hysterectomy surgery, which removes the uterus and possibly the ovaries as well in either a minimally invasive or open surgical approach.
Kecia Gaither, MD, a perinatal consultant and women’s health expert, is a double board-certified physician in OB/GYN and Maternal-Fetal Medicine in New York City. http://www.keciagaither.com

Melissa Chefec, MCPR, LLC, http://www.mcprpublicrelations.com, +1 (203) 968-6625, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.